Skip to content
NSE: SYMBIOTECISIN INE899I01028

Symbiotec Pharmalab share price today, results and news

₹1,611.30 −1.89% (−₹31.10) Close on 13 Nov 2026
In short

Symbiotec Pharmalab closed at ₹1,611.30 on 13 Nov 2026, down 1.89% on the day. It is 2.6% below its 52-week high of ₹1,655.00 and 72.5% above its 52-week low of ₹934.20.

At a glance

Previous close
₹1,642.40
Open
₹1,635.00
Day’s range
₹1,586.60 – 1,635.00
Volume
2,71,823
52-week low ₹934.2052-week high ₹1,655.00

Last closing price. Updated after each trading day.

Earnings

Symbiotec Pharmalab quarterly results and earnings call

Latest results

Q1FY27Apr–Jun 2026 quarterResults due by 14 Aug 2026
Share price since 1 Sep 2026+46.79%
Revenue and profit figures from this quarter appear here once added from the company’s results.

Upcoming results

14NOVQ2 FY27 results due by 14 Nov 2026Jul–Sep 2026 quarter · due today

SEBI’s listing rules give companies 45 days after a quarter ends to publish results (60 days for the full year). The exact board-meeting date is announced to the stock exchanges beforehand.

Latest earnings call

Companies usually hold the call on the day of their results or the day after, and post the recording and transcript on their website.

Find the latest transcript (opens in a new tab)

5 things to know about Symbiotec Pharmalab today

  1. Closed at ₹1,611.30 on 13 Nov 2026, down 1.89% on the day.
  2. Trades 2.6% below its 52-week high of ₹1,655.00 (12 Nov 2026) and 72.5% above its 52-week low of ₹934.20.
  3. 2,71,823 shares traded in the last session, 0.3× the 20-day average.
From closing prices to 13 Nov 2026. The top 5 points from the next earnings call of Symbiotec Pharmalab will appear here once added.

Share price vs Nifty 50

Share price returns compared with the Nifty 50
PeriodSYMBIOTECNifty 50
1 month+28.57%+11.15%
The company’s latest investor presentation will appear here once added. Find the latest investor presentation (opens in a new tab)

Quarter-on-quarter and year-on-year figures for Symbiotec Pharmalab have not been added yet.

Technical indicators

Symbiotec Pharmalab technical indicators

Calculated from daily closing prices up to 13 Nov 2026. They describe past prices only and are not a forecast.

RSI (14 days)
71.7Above 70

RSI compares recent gains with recent losses on a 0 to 100 scale. Readings above 70 are commonly described as overbought and below 30 as oversold.

MACD (12, 26, 9)
113.35Above signal line

The MACD line is above its 9-day signal line (78.59). MACD tracks the gap between the 12-day and 26-day exponential averages.

20-day average
₹1,340.91Price above

The close is 20.2% above the average closing price of the last 20 trading days.

50-day average
₹1,205.76Price above

The close is 33.6% above the average closing price of the last 50 trading days.

52-week range
94%Of the range

The close is 94% of the way from the 52-week low (₹934.20, 1 Sep 2026) to the high (₹1,655.00, 12 Nov 2026).

Volume vs average
0.3×Lower than usual

2,71,823 shares traded in the last session, against a 20-day average of 10,42,982.

FAQ

Questions about Symbiotec Pharmalab

What is the share price of Symbiotec Pharmalab today?

Symbiotec Pharmalab closed at ₹1,611.30 on 13 Nov 2026, down 1.89% from the previous close of ₹1,642.40 on the NSE.

What is the 52-week high and low of Symbiotec Pharmalab?

In the last 52 weeks Symbiotec Pharmalab traded between a low of ₹934.20 on 1 Sep 2026 and a high of ₹1,655.00 on 12 Nov 2026. The last close is 2.6% below the high.

How has Symbiotec Pharmalab stock performed recently?

Based on closing prices up to 13 Nov 2026, Symbiotec Pharmalab shares are up 28.6% over one month.

What is the stock symbol and ISIN of Symbiotec Pharmalab?

Symbiotec Pharmalab is listed on the National Stock Exchange (NSE) under the symbol SYMBIOTEC. Its ISIN is INE899I01028.

About this data

  • Prices and indicators: last closing prices, updated 13 Nov 2026, 4:20 pm IST.
  • Headlines: linked to the publisher that reported them. We store only the headline, link and date.

Disclaimer: Marketasset is an information service and is not registered with SEBI as an investment adviser or research analyst. We do not publish our own analysis or ratings of any stock. Prices are the last closing prices, technical indicators are calculated from past prices, headlines link to the original publisher and company figures come from the company’s own published documents. Nothing here is a recommendation to buy, sell or hold any security.

Scroll to Top